Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Publication Timetable

This timetable will be updated when publication dates are finalised.

Sodium Valproate and Topiramate Monitoring Report – Q4 2025/26 28th May 2026
General Medical Q4 2025/26

4th June 2026

General Medical Annual 2025/26

4th June 2026

Ophthalmic Q4 2025/26

11th June 2026

Ophthalmic Annual 2025/26 11th June 2026
Dental Q4 2025/26

18th June 2026

Dental Annual 2025/26

18th June 2026

Pharmaceutical Services Q4 2025/26

25th June 2026

Pharmaceutical Annual 2025/26

25th June 2026

FPS Key Facts Annual 2025/26

2nd July 2026

Dental Q1 2026/27

July 2026

Ophthalmic Q1 2026/27

August 2026

General Medical Q1 2026/27

August 2026

Sodium Valproate and Topiramate Monitoring Report – Q1 2026/27

August 2026

Pharmaceutical Services Q1 2026/27

August 2026

Dental Q2 2026/27

October 2026

Ophthalmic Q2 2026/27

November 2026

General Medical Q2 2026/27 November 2026
Sodium Valproate and Topiramate Monitoring Report – Q2 2026/27

November 2026

Pharmaceutical Services Q2 2026/27

November 2026

Dental Q3 2026/27

January 2027

Ophthalmic Q3 2026/27

February 2027

General Medical Q3 2026/27 February 2027
Prescription Cost Analysis 2026 February 2027
Sodium Valproate and Topiramate Monitoring Report – Q3 2026/27

February 2027

Pharmaceutical Services Q3 2026/27

February 2027

 

The Prescription Cost Analysis is normally published annually in February, with annual General Medical, Ophthalmic, Dental and Pharmaceutical publications in June and the Annual Key Facts publication in July.

Monthly datasets, such as GP Prescribing and Dispensing by Contractor, are dependent on the completion of pharmacy payment processes but will be published on or before the 10th of each month.